摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-benzyl-3,4-dihydro-2H-benzo[b][1,4]oxazine-2-carboxamide | 212578-42-2

中文名称
——
中文别名
——
英文名称
4-benzyl-3,4-dihydro-2H-benzo[b][1,4]oxazine-2-carboxamide
英文别名
4-Benzyl-2,3-dihydro-1,4-benzoxazine-2-carboxamide
4-benzyl-3,4-dihydro-2H-benzo[b][1,4]oxazine-2-carboxamide化学式
CAS
212578-42-2
化学式
C16H16N2O2
mdl
——
分子量
268.315
InChiKey
GALOEUXPVXRQSR-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.3
  • 重原子数:
    20
  • 可旋转键数:
    3
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.19
  • 拓扑面积:
    55.6
  • 氢给体数:
    1
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • [EN] SUBSTITUTED 4-BENZYL-3,4-DIHYDRO-2H-BENZO[B][1,4]OXAZINE-2CARBOXAMIDE ANALOGS AS POSITIVE ALLOSTERIC MODULATORS OF MUSCARINIC ACETYCHOLINE RECEPTOR M1<br/>[FR] ANALOGUES SUBSTITUÉS DU 4-BENZYL-3,4-DIHYDRO-2H-BENZO[B] [1,4] OXAZINE-2-CARBOXAMIDE, UTILISÉS COMME MODULATEURS ALLOSTÉRIQUES POSITIFS DU RÉCEPTEUR MUSCARINIQUE DE L'ACÉTYLCHOLINE M1
    申请人:UNIV VANDERBILT
    公开号:WO2015080904A1
    公开(公告)日:2015-06-04
    In one aspect, the invention relates to N-substituted 3,4-dihydro-benzo[£][l,4]oxazine-2-carboxamide analogs, derivatives thereof, and related compounds, which are useful as positive allosteric modulators of the muscarinic acetylcholine receptor M1 (mAChR M1); synthesis methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of treating neurological and psychiatric disorders associated with muscarinic acetylcholine receptor dysfunction using the compounds and compositions. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
    在一个方面,这项发明涉及N-取代的3,4-二氢苯并[£][1,4]噁嗪-2-羧酰胺类似物,其衍生物和相关化合物,这些化合物可用作肌胆碱受体M1(mAChR M1)的正向变构调节剂;制备这些化合物的合成方法;包含这些化合物的药物组合物;以及使用这些化合物和组合物治疗与肌胆碱受体功能障碍相关的神经和精神疾病的方法。本摘要旨在作为在特定领域搜索的扫描工具,并不意味着对本发明的限制。
  • Discovery of Dihydro-1,4-Benzoxazine Carboxamides as Potent and Highly Selective Inhibitors of Sirtuin-1
    作者:Martin Spinck、Matthias Bischoff、Philipp Lampe、Franz-Josef Meyer-Almes、Sonja Sievers、Heinz Neumann
    DOI:10.1021/acs.jmedchem.1c00017
    日期:2021.5.13
  • New Substituted 1,4-Benzoxazine Derivatives with Potential Intracellular Calcium Activity
    作者:Anne-Sophie Bourlot、Isabel Sánchez、Georges Dureng、Gérald Guillaumet、Roy Massingham、André Monteil、Eileen Winslow、M. Dolors Pujol、Jean-Yves Mérour
    DOI:10.1021/jm970795t
    日期:1998.8.1
    Substituted 1,4-benzoxazines bearing an amino side chain at the 2-position were prepared and were found to have a moderate activity on intracellular calcium. Of the compounds studied it was found that those which possess a homoveratrylamino moiety exhibited superior potency. The chain length and the nature of the amine (4-fluorophenylpiperazine, 4-fluorobenzhydryloxyethylamine, N-substituted homoveratrylamine) is discussed. The 4-benzyl-3,4-dihydro-2[3-[[2-(3,4-dimethoxyphenyl)ethyl]amino]propyl]-2H-1,4-benzoxazine (3c) is the most potent derivative of the series with a ratio of IC50 values against PE (phenylephrine) and K+ of 2.1. Under these test conditions a ratio near 1 indicates potential intracellular calcium activity while a ratio greater than 100 an action on extracellular calcium influx.
  • BUTLER, R. C. M.;CHAPLEO, CH. B.;MYERS, P. L.;WELBOURN, A. P., J. HETEROCYCL. CHEM., 1985, 22, N 1, 177-181
    作者:BUTLER, R. C. M.、CHAPLEO, CH. B.、MYERS, P. L.、WELBOURN, A. P.
    DOI:——
    日期:——
  • SUBSTITUTED 4-BENZYL-3,4-DIHYDRO-2H-BENZO[B][1,4]OXAZINE-2CARBOXAMIDE ANALOGS AS POSITIVE ALLOSTERIC MODULATORS OF MUSCARINIC ACETYCHOLINE RECEPTOR M1
    申请人:Vanderbilt University
    公开号:US20170022173A1
    公开(公告)日:2017-01-26
    In one aspect, the invention relates to N-substituted 3,4-dihydro-benzo[£][1,4]oxazine-2-carboxamide analogs, derivatives thereof, and related compounds, which are useful as positive allosteric modulators of the muscarinic acetylcholine receptor M 1 (mAChR M 1 ); synthesis methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of treating neurological and psychiatric disorders associated with muscarinic acetylcholine receptor dysfunction using the compounds and compositions. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
查看更多